Jolanta M. Siller‐Matula

Medical University of Warsaw — Poland

Medicine · Health Sciences

54h-index15.0kcitations287works12.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Antiplatelet Therapy and Cardiovascular Diseases(133), Atrial Fibrillation Management and Outcomes(72), Acute Myocardial Infarction Research(62), Coronary Interventions and Diagnostics(45), Venous Thromboembolism Diagnosis and Management(44)

Publications286 total

Impact of direct oral anticoagulants on target lesion revascularization rates in patients with chronic coronary syndrome
Journal of Thrombosis and Haemostasis·2025· 1 citedOpen Access
A multicentre observational study on landiolol use, efficacy, and safety in European patients with supraventricular arrhythmia (Landi-UP)
European Heart Journal Acute Cardiovascular Care·2025· 1 citedOpen Access
2025 Focused Update of the 2019 ESC/EAS Guidelines for the management of dyslipidaemias
European Heart Journal·2025· 169 citedOpen Access
One-year clinical outcomes in patients with acute coronary syndrome treated with clopidogrel versus prasugrel versus ticagrelor: Results of the Polish Registry of Acute Coronary Syndromes (PL-ACS)
Kardiologia Polska·2025Open Access
906-P: The Predictive Value of Sirtuins and miRNAs in Cardiac Recovery after Acute Myocardial Infarction Treated with Empagliflozin
Diabetes·2025
Bleeding complications in patients with out-of-hospital cardiac arrest treated with cangrelor and oral P2Y12 inhibitors
European Heart Journal Acute Cardiovascular Care·2025· 2 citedOpen Access
Antithrombotic drugs for acute coronary syndromes in women: sex-adjusted treatment and female representation in randomised clinical trials. A clinical consensus statement of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) and the ESC Working Group on Thrombosis
EuroIntervention·2025· 1 citedOpen Access
Antithrombotic drugs for acute coronary syndromes in women: sex-adjusted treatment and female representation in randomised clinical trials. A clinical consensus statement of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) and the ESC Working Group on Thrombosis
European Heart Journal·2025· 5 citedOpen Access
Management of patients with congenital bleeding disorders and cardiac indications for antithrombotic therapy
European Heart Journal - Cardiovascular Pharmacotherapy·2025· 5 citedOpen Access
Early treatment with inhibitors of P2Y12 receptor in patients with ST-segment elevation myocardial infarction — 2023 ESC recommendations and scientific evidence. Is clinical evidence sufficient to suggest a move towards precision medicine? The ELECTRA-SIRIO 2 investigators’ viewpoint
Cardiology Journal·2025Open Access
Maintenance therapy with a P2Y12 receptor inhibitor after cangrelor in patients with acute coronary syndrome. The ELECTRA-SIRIO 2 investigators’ viewpoint
Cardiology Journal·2025Open Access
Prolonged antithrombotic treatment after de-escalation of dual antiplatelet therapy in patients after acute coronary syndrome - which strategy should be applied? The ELECTRA-SIRIO 2 investigators standpoint
International Journal of Cardiology·2024· 2 cited
Abstract 4139864: Effect of P2Y12 Inhibitors on Plasma Metabolomic Changes in Patients with Acute Myocardial Infarction
Circulation·2024
International Consensus Statement on Platelet Function and Genetic Testing in Percutaneous Coronary Intervention
JACC: Cardiovascular Interventions·2024· 73 cited
Impact of empagliflozin on cardiac structure and function assessed by echocardiography after myocardial infarction: a post-hoc sub-analysis of the emmy trial
Clinical Research in Cardiology·2024· 4 citedOpen Access
Prediction model for leaflet thrombosis in patients undergoing transcatheter aortic valve implantation: the EFFORT study
Clinical Research in Cardiology·2024· 3 citedOpen Access
141-OR: Cardioprotective Effect of Empagliflozin and Modification of Sirtuins and Their Noncoding RNAs Regulators in Patients with Myocardial Infarction
Diabetes·2024
Landiolol for refractory ventricular fibrillation in out-of-hospital cardiac arrest: A randomized, double-blind, placebo-controlled, pilot trial
Resuscitation·2024· 16 citedOpen Access
Alteration of circulating ACE2-network related microRNAs in patients with COVID-19
Scientific Reports·2024· 3 citedOpen Access
Ticagrelor downregulates the expression of proatherogenic and proinflammatory miR125-b compared to clopidogrel: A randomized, controlled trial
International Journal of Cardiology·2024· 2 citedOpen Access
page 1 of 15Next →

Frequent Co-authors

Bernd Jilma(18), Kurt Huber(14), Jacek Kubica(8), Tobias Geisler(7), Robert F. Storey(7), Eliano Pio Navarese(7), Marek Postuła(7), Sigrun Halvorsen(6), Dirk Sibbing(6), Jurriën M. ten Berg(6), Iréne Lang(6), Marek Koziński(6), Jean‐Philippe Collet(5), Diana A. Gorog(5), Dietmar Trenk(5), Ceren Eyileten(5), Georg Delle‐Karth(5), Borja Ibáñez(4), Davide Capodanno(4), Konstantinos C. Koskinas(4)